Literature DB >> 20043966

Neuronal differentiation by analogs of staurosporine.

Alex F Thompson1, Leonard A Levin.   

Abstract

RGC-5 cells are transformed cells that express several surface markers characteristic of neuronal precursor cells, but resemble glial cells morphologically and divide in culture. When treated with the apoptosis-inducing agent staurosporine, RGC-5 cells assume a neuronal morphology, extend neurites, stop dividing, and express ion channels without acute signs of apoptosis. This differentiation with staurosporine is similar to what has been described for certain other neuronal cell lines, and occurs by a mechanism not yet understood. Inhibition of several kinases known to be inhibited by staurosporine fails to differentiate RGC-5 cells, and examination of the kinome associated with staurosporine-dependent differentiation has been unhelpful so far. To better understand the mechanism of staurosporine-mediated differentiation of neuronal precursor cells, we studied the effects of the following structurally similar molecules on differentiation of neuronal and non-neuronal cell lines, comparing them to staurosporine: 9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, 2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-, methyl ester, (9S,10R,12R)-(K252a), (5R,6S,8S)-6-hydroxy-5-methyl-13-oxo-6,7,8,13,14,15-hexahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacene-6-carboxylic acid (K252b), staurosporine aglycone (K252c), 7-hydroxystaurosporine (UCN-01), and 4'-N-benzoylstaurosporine (PKC-412). Morphological differentiation, indicated by neurite extension and somal rounding, was quantitatively assessed with NeuronJ. We found that the critical structural component for differentiation in RGC-5 cells is a basic amine adjacent to an accessible methoxy group at the 3' carbon. Given that UCN-01 and similar compounds are potent anti-cancer drugs, examination of molecules that share similar structural features may yield insights into the design of other drugs for differentiation. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20043966      PMCID: PMC2831141          DOI: 10.1016/j.neuint.2009.12.018

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  26 in total

1.  Staurosporine-induced neurite outgrowth in PC12h cells.

Authors:  S Hashimoto; A Hagino
Journal:  Exp Cell Res       Date:  1989-10       Impact factor: 3.905

2.  K-252a: a specific inhibitor of the action of nerve growth factor on PC 12 cells.

Authors:  S Koizumi; M L Contreras; Y Matsuda; T Hama; P Lazarovici; G Guroff
Journal:  J Neurosci       Date:  1988-02       Impact factor: 6.167

Review 3.  Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases.

Authors:  U T Rüegg; G M Burgess
Journal:  Trends Pharmacol Sci       Date:  1989-06       Impact factor: 14.819

4.  Mimicry and inhibition of nerve growth factor effects: interactions of staurosporine, forskolin, and K252a in PC12 cells and normal rat chromaffin cells in vitro.

Authors:  A S Tischler; L A Ruzicka; R L Perlman
Journal:  J Neurochem       Date:  1990-10       Impact factor: 5.372

5.  Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.

Authors:  T Tamaoki; H Nomoto; I Takahashi; Y Kato; M Morimoto; F Tomita
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

6.  Induction of a common pathway of apoptosis by staurosporine.

Authors:  R Bertrand; E Solary; P O'Connor; K W Kohn; Y Pommier
Journal:  Exp Cell Res       Date:  1994-04       Impact factor: 3.905

7.  Staurosporine-induced morphological differentiation of human neuroblastoma cells.

Authors:  T B Shea; M L Beermann
Journal:  Cell Biol Int Rep       Date:  1991-02

8.  A system for characterizing cellular and molecular events in programmed neuronal cell death.

Authors:  R N Pittman; S Wang; A J DiBenedetto; J C Mills
Journal:  J Neurosci       Date:  1993-09       Impact factor: 6.167

9.  Staurosporine induces a neuronal phenotype in SH-SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12-O-tetradecanoyl phorbol-13 acetate (TPA).

Authors:  A Jalava; J Heikkilä; M Lintunen; K Akerman; S Påhlman
Journal:  FEBS Lett       Date:  1992-03-30       Impact factor: 4.124

10.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  L A Greene; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

View more
  7 in total

1.  Staurosporine-induced differentiation of the RGC-5 cell line leads to apoptosis and cell death at the lowest differentiating concentration.

Authors:  Maximillian Schultheiss; Sven Schnichels; Kapka Miteva; Katrin Warstat; Peter Szurman; Martin S Spitzer; Sophie Van Linthout
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-06       Impact factor: 3.117

2.  Staurosporine analogs promote distinct patterns of process outgrowth and polyploidy in small cell lung carcinoma cells.

Authors:  Hichem Gallala; Jochen Winter; Nadine Veit; Michael Nowak; Sven Perner; Cornelius Courts; Dominik Kraus; Viktor Janzen; Rainer Probstmeier
Journal:  Tumour Biol       Date:  2014-12-07

3.  Induction of Neuronal Morphology in the 661W Cone Photoreceptor Cell Line with Staurosporine.

Authors:  Alex F Thompson; Megan E Crowe; Christopher J Lieven; Leonard A Levin
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

4.  High-throughput screen for compounds that modulate neurite growth of human induced pluripotent stem cell-derived neurons.

Authors:  Sean P Sherman; Anne G Bang
Journal:  Dis Model Mech       Date:  2018-02-02       Impact factor: 5.758

5.  Staurosporine and extracellular matrix proteins mediate the conversion of small cell lung carcinoma cells into a neuron-like phenotype.

Authors:  Tamara Murmann; Carmen Carrillo-García; Nadine Veit; Cornelius Courts; Alexander Glassmann; Viktor Janzen; Burkhard Madea; Markus Reinartz; Anne Harzen; Michael Nowak; Sven Perner; Jochen Winter; Rainer Probstmeier
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

6.  Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.

Authors:  Tiago Elias Heinen; Rafael Pereira Dos Santos; Amanda da Rocha; Michel Pinheiro Dos Santos; Patrícia Luciana da Costa Lopez; Marco Aurélio Silva Filho; Bárbara Kunzler Souza; Luís Fernando da Rosa Rivero; Ricardo Gehrke Becker; Lauro José Gregianin; Algemir Lunardi Brunetto; André Tesainer Brunetto; Caroline Brunetto de Farias; Rafael Roesler
Journal:  Oncotarget       Date:  2016-06-07

7.  Self-renewing Monolayer of Primary Colonic or Rectal Epithelial Cells.

Authors:  Yuli Wang; Matthew DiSalvo; Dulan B Gunasekara; Johanna Dutton; Angela Proctor; Michael S Lebhar; Ian A Williamson; Jennifer Speer; Riley L Howard; Nicole M Smiddy; Scott J Bultman; Christopher E Sims; Scott T Magness; Nancy L Allbritton
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.